SEMA-CardioDiab HUNGARY: A Research Study to Understand the Effects of Oral Semaglutide on Blood Sugar Levels, Weight, and Cardiovascular Risk in People With Type 2 Diabetes Patients in Hungary
Clinical trial NCT06269120 · COMPLETED
Trial details
- NCT number
- NCT06269120
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2024-09-30
- Primary completion
- 2026-05-05
- Enrollment
- 243
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.